Journal article
What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic Review.
Abstract
OBJECTIVES: The introduction of new oral anticoagulants for the prevention of stroke in atrial fibrillation (AF) has changed the clinical management of AF. To inform decision making around dabigatran by identifying factors influencing cost-effectiveness results, we undertook a systematic review of economic evaluations of dabigatran versus warfarin for the prevention of stroke in AF patients.
METHODS: A systematic literature search of Ovid …
Authors
Jegathisawaran J; Holbrook A; Bowen JM; Burke N; Campbell K; Tarride J-E
Journal
Journal of Population Therapeutics and Clinical Pharmacology, Vol. 24, No. 2, pp. e1–e20
Publisher
Codon Publications
DOI
10.22374/1710-6222.24.2.1
ISSN
1710-6222